T505-1317 Screening compound: 1-(2-{1-[2-(benzyloxy)acetyl]piperidin-2-yl}ethyl)-N-cyclopropyl-1H-1,2,3-triazole-4-carboxamide

T505-1317 Screening compound: 1-(2-{1-[2-(benzyloxy)acetyl]piperidin-2-yl}ethyl)-N-cyclopropyl-1H-1,2,3-triazole-4-carboxamide
T505-1317 Screening compound: 1-(2-{1-[2-(benzyloxy)acetyl]piperidin-2-yl}ethyl)-N-cyclopropyl-1H-1,2,3-triazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T505-1317
1-(2-{1-[2-(benzyloxy)acetyl]piperidin-2-yl}ethyl)-N-cyclopropyl-1H-1,2,3-triazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T505-1317

Molecular Formula

C22H29N5O3 (C22 H29 N5 O3)

Compound Name

1-(2-{1-[2-(benzyloxy)acetyl]piperidin-2-yl}ethyl)-N-cyclopropyl-1H-1,2,3-triazole-4-carboxamide

IUPAC name

1-(2-{1-[2-(benzyloxy)acetyl]piperidin-2-yl}ethyl)-N-cyclopropyl-1H-123-triazole-4-carboxamide

SMILES

O=C(COCc1ccccc1)N1C(CCn2nnc(C(NC3CC3)=O)c2)CCCC1

InChI

InChI=1S/C22H29N5O3/c28-21(16-30-15-17-6-2-1-3-7-17)27-12-5-4-8-19(27)11-13-26-14-20(24-25-26)22(29)23-18-9-10-18/h1-3,6-7,14,18-19H,4-5,8-13,15-16H2,(H,23,29)/t19-/m1/s1

InChI Key

OFLWWJGCGMHPGO-LJQANCHMSA-N

MDL Number (MFCD)

MFCD31998936

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.835

Distribution Coefficient, logD

1.835

Water Solubility, LogSw

-1.91

Polar Surface Area

75.401

Acid Dissociation Constant (pKa)

12.48

Base Dissociation Constant (pKb)

-0.26

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

54.54

T505-1317 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GABA Library (7115 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with T505-1317 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T505-1317?
Check Price and Availability of T505-1317, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T505-1317 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T505-1317
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T505-1317
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T505-1317 available by request